Fol. Biol. 2018, 64, 31-34
https://doi.org/10.14712/fb2018064010031
Buccal Respiratory Chain Complexes I and IV Quantities in Huntington’s Disease Patients
References
1. 2010) Neuronal expression of a single-subunit yeast NADH-ubiquinone oxidoreductase (Ndi1) extends Drosophila lifespan. Aging Cell 9, 191-202.
< , S., Cho, J., Lo, T., Contreras, H., Lawal, H. O., Krantz, D. E., Bradley, T. J., Walker, D. W. (https://doi.org/10.1111/j.1474-9726.2010.00546.x>
2. 2007) Activities of respiratory chain complexes in isolated platelets in females with anorexia nervosa. Int. J. Eat. Disord. 40, 659-663.
< , M., Papezova, H., Hansikova, H., Wenchich, L., Zeman, J. (https://doi.org/10.1002/eat.20403>
3. 1985) Regional mitochondrial respiratory activity in Huntington’s disease brain. J. Neurochem. 44, 1948-1950.
< , W., Bird, E., Aprille, J. (https://doi.org/10.1111/j.1471-4159.1985.tb07192.x>
4. 1997) Oxidative damage and metabolic dysfunction in Huntington’s disease: selective vulnerability of the basal ganglia. Ann. Neurol. 41, 646-653.
< , S., Bowling, A., Macgarvey, U., Baik, J. M., Berger, S. C., Muquit, M. M. K., Bird, E. D., Beal, M. F. (https://doi.org/10.1002/ana.410410514>
5. 2006) Seminar on choreas. Lancet Neurol. 5, 589-602.
< , F., Seppi, K., Mair, K. J., Wenning, G. K., Poewe, W. (https://doi.org/10.1016/S1474-4422(06)70494-X>
6. 2017) Nonmotor symptoms in Huntington disease. Int. Rev. Neurobiol. 134, 1397-1408.
< , F. (https://doi.org/10.1016/bs.irn.2017.05.004>
7. 2006) Transcriptional repression of PGC-1α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69.
< , L., Jeong, H., Borovecki, F., Parkhurst, C. N., Tanese, N., Krainc, D. (https://doi.org/10.1016/j.cell.2006.09.015>
8. 2013) A role of mitochondrial Complex II defects in genetic models of Huntington’s disease expressing N-terminal fragments of mutant huntingtin. Hum. Mol. Genet. 22, 3869-3882.
< , M., Diguet, E., Malgorn, C., D’Aurelio, M., Galvan, L., Petit, F., Benhaim, L. (https://doi.org/10.1093/hmg/ddt242>
9. 2016) Dynamics of human mitochondrial Complex I assembly: implications for neurodegenerative diseases. Front. Mol. Biosci. 3, 43.
< , G., Bouverot, R., Acajjaoui, S., Pantalone, S., Soler- López, M. (https://doi.org/10.3389/fmolb.2016.00043>
10. 2015) Mitochondrial enzyme dysfunction in autism spectrum disorders; a novel biomarker revealed from buccal swab analysis. Biomarkers Med. 9, 957-965.
< , M. J., Damle, S., Sheth, S., Shah, N., Melvin, J., Jethva, R., Hardison, H., Marks, H., Legido, A. (https://doi.org/10.2217/bmm.15.72>
11. 1996) Mitochondrial defect in Huntington’s disease caudate nucleus. Ann. Neurol. 39, 385-389.
< , M., Gash, M. T., Mann, V. M., Javoy-Agid, F., Cooper, J. M., Schapira, A. H. V. (https://doi.org/10.1002/ana.410390317>
12. 2009) Research electronic data capture (REDCap) – a metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377-381.
< , P. A., Taylor, R., Thielke, R., Payne, J., Gonzalez, N., Conde, J. G. (https://doi.org/10.1016/j.jbi.2008.08.010>
13. 1993) Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2, 2069-2073.
< , A. T., Willemsen, R., Meyer, N., de Rooij, K. E., Roos, R. A., van Ommen, G. J., Galjaard, H. (https://doi.org/10.1093/hmg/2.12.2069>
14. 2013) Increased longevity mediated by yeast NDI1 expression in Drosophila intestinal stem and progenitor cells. Aging (Albany) 5, 662-681.
< , J. H., Bahadorani, S., Graniel, J., Koehler, C. L,. Ulgherait, M., Rera, M., Jones, D. L., Walker, D. W. (https://doi.org/10.18632/aging.100595>
15. 2010) Mitochondrial loss, dysfunction and altered dynamics in Huntington’s disease. Hum. Mol. Genet. 19, 3919-3935.
< , J., Moody, J. P., Edgerly, C. K., Bordiuk, O. L., Cormier, K., Smith, K., Beal, M. F., Ferrante, R. J. (https://doi.org/10.1093/hmg/ddq306>
16. 2015) Upregulation of cytochrome c oxidase subunit 6b1 (Cox6b1) and formation of mitochondrial supercomplexes: implication of Cox6b1 in the effect of calorie restriction. Age (Dordr) 37, 9787.
< , S. E., Mori, R., Komatsu, T., Chiba, T., Hayashi, H., Park, S., Sugawa, M. D., Dencher, N. A., Shimokawa, I. (https://doi.org/10.1007/s11357-015-9787-8>
17. 2005) Čes. a Slov. Neurol. Neurochir. 68/101, 169-174. (in Czech)
, J., Hansíková, H., Roth, J., Židovská, J., Böhm, M., Zeman, J. (
18. 2016) Visuospatial processing deficits linked to posterior brain regions in premanifest and early stage Huntington’s disease. J. Int. Neuropsychol. Soc. 22, 595-608.
< , I, Cassidy, A. M., Scahill, R. I., Johnson, E. B., Rees, E., O’Regan, A., Queller, S. (https://doi.org/10.1017/S1355617716000321>
19. 1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
< , O. H., Rosebrough, R. J., Farr, A. L., Randall, R. J. (https://doi.org/10.1016/S0021-9258(19)52451-6>
20. 2014) The Huntington’s disease- related cardiomyopathy prevents a hypertrophic response in the R6/2 mouse model. PloS One 9, e108961.
< , M., Bondulich, M. K., Inuabasi, L., Franklin, S. A., Muller, T., Bates, G. P. (https://doi.org/10.1371/journal.pone.0108961>
21. 2007) Python for scientific computing. Comput. Sci. Eng. 9, 10-20.
< , T. E. (https://doi.org/10.1109/MCSE.2007.58>
22. 2002) Early mitochondrial calcium defects in Huntington’s disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731-736.
< , A. V., Gutekunst, C. A., Leavitt, B. R., Hayden, M. R., Burke, J. R., Strittmatter, W. J., Greenamyre, J. T. (https://doi.org/10.1038/nn884>
23. 2011) Platelet mitochondrial Complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism. J. Cereb. Blood Flow Metab. 31, e1-5.
< , W. J., Haas, R. H., Le, T., Videen, T. O., Markham, J., Perlmutter, J. S. (https://doi.org/10.1038/jcbfm.2010.179>
24. 2017) Auditory dysfunction in patients with Huntington’s disease. Clin. Neurophysiol. 128, 1946-1953.
< , O., Roth, J., Bureš, Z., Balogová, Z., Lišková, I., Betka, J., Syka, J. (https://doi.org/10.1016/j.clinph.2017.07.403>
25. 2016) The prevalence of Huntington’s disease. Neuroepidemiology 46, 144-153.
< , M. D., Wexler, N. S., Wexler, A. R., Tabrizi, S. J., Douglas, I., Evans, S. J. W., Smeeth, L. (https://doi.org/10.1159/000443738>
26. 2009) Amyloid-β and τ synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice. Proc. Natl. Acad. Sci. USA 106, 20057-20062.
< , V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L. (https://doi.org/10.1073/pnas.0905529106>
27. 2014) Non-invasive screening of cytochrome c oxidase deficiency in children using a dipstick immunocapture assay. Folia Biol. (Praha) 60, 268-274.
, M., Trefilová, E., Honzík, T., Tesařová, M., Zeman, J., Hansíková, H. (
28. 2010) Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction. Proc. Natl. Acad. Sci. USA 107, 9105-9110.
< , A., Soikkeli, M., Portero-Otín, M., Wilson, A., Kemppainen, E., McIlroy, G., Ellilä, S., Kemppainen, K. K., Tuomela, T., Lakanmaa, M., Kiviranta, E., Stefanatos, R., Dufour, E., Hutz, B., Naudí, A., Jové, M., Zeb, A., Vartiainen, S., Matsuno-Yagi, A., Yagi, T., Rustin, P., Pamplona, R., Jacobs, H.,T. (https://doi.org/10.1073/pnas.0911539107>
29. 2013) Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington’s disease carriers. Mitochondrion 13, 801-809.
< , A. C., Almeida, S., Laço, M., Duarte, A. I., Domingues, J., Oliveira, C. R., Januário, C., Rego, A. C. (https://doi.org/10.1016/j.mito.2013.05.006>
30. 2006) Cytotoxicity of a mutant Huntingtin fragment in yeast involves early alterations in mitochondrial OXPHOS Complexes II and III. Hum. Mol. Genet. 15, 3063-3081.
< , A., Zambrano, A., Rodríguez, M., Barrientos, A. (https://doi.org/10.1093/hmg/ddl248>
31. 1999) Biochemical abnormalities and excitotoxicity in Huntington’s disease brain. Ann. Neurol. 45, 25-32.
< , S. J., Cleeter, M. W., Xuereb, J., Taanman, J. W., Cooper, J. M., Schapira, A. H. (https://doi.org/10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E>